Home -> Law Blog Directory -> International Law Blogs -> Australian Regulatory Compliance Review
(866) 635-2689 for Personal Injury or (866) 635-9402 for Criminal Defense
Find a Local Lawyer
Divorce (866) 635-6190
Personal Injury (866) 635-2689
Criminal Defense (866) 635-9402
International Law
: Australian Regulatory Compliance ReviewRisk issues for 2008
Although we are starting the year with market uncertainty and credit tightening because of the sub-prime mortgage crisis, the larger issue is business judgment. How good are the risk management and decision-making processes of organisations which cannot calculate or understand the risks of the transactions they enter? And how do you know if a key customer or supplier is affected? In this note I identify 3 of the risks you need to manage.
The flow-on effects of the US sub-prime mortgage crisis for the Australian stock market and financial system were unforeseen, it seems, because of ambiguous or misleading disclosure to the market.
So the first risk issue businesses need to consider is how good are your disclosure procedures and those of the businesses you deal with. If you are listed you need to review your continuous disclosure obligations. Even if your company is not listed, if you are a director or manager, are you satisfied you have identified key contracts and risks and understand them? Importantly, are you managing your liquidity risk? Have you reviewed your outsourcing arrangements?
The second risk is privacy and data security. Whether your data is electronically or physically stored, is it secure?
Could the UK Norwich Union Life fraud happen to you?
Do you have a data management and document retention system?
The third risk is errors from complex product packaging: whether you produce or sell consumer goods or financial products do you understand your products and market them accurately? The risk of misleading or deceptive advertising (no matter how innocent) or incorrect calculations or pricing is ongoing.
If you don't have a risk management system in place how do you know whether these risks are high or low risks for you?
Full post as published by Australian Regulatory Compliance Review on January 28, 2008 (boomark / email).
Transportation Equity Act for the 21st Century
TEA-21 - Plus Law 105-178
Zonisamide
FDA Issues Information on Risk for Metabolic Acidosis
FDA Issues Safety Warning About Valproic Acid and Divalproex Sodium
Valproic Acid and Divalproex Sodium FDA Issues Safety Warning About Risk for Birth Defects
Cipro
The FDA is seeking to add black box warnings of the risk of tendon rupture associated with Cipro and Levaquin.
The ruptures can involve Achilles tendon, shoulder, hand, bicep or thumb tendons, and is especially increased in patients older than 60, or people who have received kidney, heart or lung transplants, as well as people on steroid therapy...
FDA Issues Warning Regarding Topical Ibuprofen Drug Products
Topical Ibuprofen Drug Products FDA Issues Warning Letters
FDA Issues Update on Safety Review Orlistat
Orlistat FDA Issues Update on Safety Review
FDA Issues Warning about Promethazine Hydrochloride Injection
Promethazine Hydrochloride Injection FDA issues warning

Georgetown Law Journal, Issue 97.1 (November 2008)
Increasing Risk, Increasing Insurance Role.
Cox Announces Expansion of SEC Office of Risk Assessment
Older Patients Who Take Avandia Have Higher Risk of Heart Attacks








